Skip to content
akaturk Academic measurement
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 118
YÖKSİS118 OpenAlex0
Projects 4
Books 15
Proceedings 104

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 94
h-index 12 Percentile in Türkiye: 90 #174 of 1,639 at their university by h-index
i10-index
18
Total citations
498
Top 11% in Türkiye
Per article
5.3
FWCI
0.79
1.00 = world average
World top 1%
0
World top 10%
6

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 79
  • Q1 18
  • Q2 41
  • Q3 11
  • Q4 9
WoS (JCR) 80
  • Q1 15
  • Q2 21
  • Q3 23
  • Q4 21
TR Index TR Index

40 articles

OpenAlex citation percentile
  • Top 1% 0
  • Top 10% 6
  • Avg 55.5%
  • n 93
Other counts

Scopus (SJR)

  • Excluding abstracts 76 Q1 15 Q2 41 Q3 11 Q4 9
  • YÖKSİS rows 79

WoS (JCR)

  • Excluding abstracts 77 Q1 12 Q2 21 Q3 23 Q4 21
  • YÖKSİS rows 80

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Journals with publications

58 journals

Article list

  1. 2026 The Effect of Adding Paraffin Bath to the Therapeutic Hand Exercise Programme on Hand Functions in Patients with Systemic Sclerosis: A Randomized, Controlled, Single-Blind Study Archives of Rheumatology DOI 10.5152/ArchRheumatol.2026.25096 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 11.6%
  2. 2026 Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study Therapeutic Advances in Musculoskeletal Disease DOI 10.1177/1759720X261469258 YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.5%
  3. 2026 Can M-score be used to predict recurrence in IGM patients? European Journal of Medical Research DOI 10.1186/s40001-026-04053-0 YÖKSİS SJR Q2 JCR Q2 OpenAlex 10.4%
  4. 2026 Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study Scandinavian Journal of Rheumatology DOI 10.1080/03009742.2026.2700105 YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.1%
  5. 2026 Clinical and serological predictors of autoimmune etiology in patients with interstitial lung disease: a 10-year retrospective study Clinical Rheumatology DOI 10.1007/s10067-026-08256-y YÖKSİS SJR Q2 JCR Q3 OpenAlex 54.8%
  6. 2026 Assessing multiple-choice question quality in internal medicine: a comparative analysis of three large language models against expert consensus Frontiers in Medicine DOI 10.3389/fmed.2026.1866674 YÖKSİS SJR Q1 JCR Q1 OpenAlex 63.8%
  7. 2026 Where do Glucocorticoids and Nonsteroidal Anti-Inflammatory Drugs Stand in the Treatment of Rheumatoid Arthritis in The Biologic Era? Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1918632 YÖKSİS TR Index OpenAlex 60.0%
  8. 2026 Gender-Related Differences in the Clinical, Immunological, and Treatment Characteristics of Patients with Systemic Lupus Erythematosus Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1942254 YÖKSİS TR Index OpenAlex top 10% OpenAlex 90.3%
  9. 2026 Association Between the Neutrophil-to-Lymphocyte Ratio and Recurrence in Idiopathic Granulomatous Mastitis Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1950919 YÖKSİS TR Index
  10. 2026 What Do Medical Faculty Students Think About HPV Vaccination? Uludağ Üniversitesi Tıp Fakültesi Dergisi DOI 10.32708/uutfd.1774871 YÖKSİS TR Index OpenAlex 6.1%
  11. 2025 Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study Clinical Rheumatology DOI 10.1007/s10067-025-07323-0 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 97.8%
  12. 2025 Idiopathic granulomatous mastitis: TNFi effectivity in a retrospective inception cohort Clinical Rheumatology DOI 10.1007/s10067-025-07468-y YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.6%
  13. 2025 Does the Use of Denosumab in Combination with bDMARDs or tsDMARDs Increase the Risk of Infection in Patients with Osteoporosis and Inflammatory Rheumatic Diseases? Journal of Clinical Medicine DOI 10.3390/jcm14176090 YÖKSİS SJR Q2 JCR Q1 OpenAlex 72.9%
  14. 2025 The joint ınvolvement pattern of granulomatous polangiitis changed? Multicenter study Clinical Rheumatology DOI 10.1007/s10067-025-07551-4 YÖKSİS SJR Q2 JCR Q3 OpenAlex 70.2%
  15. 2025 Real‐World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease International Journal of Rheumatic Diseases DOI 10.1111/1756-185X.70274 YÖKSİS SJR Q3 JCR Q3 OpenAlex top 10% OpenAlex 90.3%
  16. 2025 HLA B subtype analysis in patients developing tuberculosis during anti-TNF treatment Journal of scientific reports-A (Online) DOI 10.1038/s41598-025-00290-1. YÖKSİS SJR Q1 JCR Q1 OpenAlex 67.5%
  17. 2025 Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study Scand J Rheumatol. DOI 10.1080/03009742.2024.2424083. YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.4%
  18. 2025 Evaluation of Sacroiliac Joint Shape in Women with Ankylosing Spondylitis According to Mode of Birth Delivery: A Retrospective Study Medicina DOI 10.3390/medicina61010039 YÖKSİS SJR Q2 JCR Q3 OpenAlex 68.5%
  19. 2025 Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience Journal of Clinical Medicine DOI 10.3390/jcm14155181 YÖKSİS SJR Q2 JCR Q1 OpenAlex 73.8%
  20. 2025 Patients Diagnosed with Granulomatosis with Polyangiitis: The Journey to Receive Rheumatologist Care Journal of Clinical Medicine DOI 10.3390/jcm14103523 YÖKSİS SJR Q2 JCR Q1 OpenAlex 65.7%

Back to academicians